scispace - formally typeset
Search or ask a question
Topic

Epworth Sleepiness Scale

About: Epworth Sleepiness Scale is a research topic. Over the lifetime, 4742 publications have been published within this topic receiving 155088 citations.


Papers
More filters
Journal ArticleDOI
01 May 2001-Sleep
TL;DR: The results suggest that reboxetine exerts stimulant and anticataplectic effects in narcolepsy, contrary to previous thinking, by which stimulant action would require dopaminergic facilitation, noradrenergic mechanisms might be relevant to the control of wakefulness.
Abstract: Study objectives: To investigate potential stimulant and anticataplectic effects of 10 mg reboxetine in patients diagnosed with narcolepsy. Design: 12 patients were treated for a 2-week period with 10 mg reboxetine under open conditions. The dosage of reboxetine was gradually increased between Day 1 and Day 9. Outcome parameters consisted of nightime polysomnography (PSG), Multiple Sleep Latency Test (MSLT), Epworth Sleepiness Scale (ESS), Visual Analog Scale for Sleepiness (VAS), Ullanlinna Narcolepsy Scale (UNS), and the Beck Depression Inventory (BDI). Setting: Sleep Disorders Clinic at a University Hospital. Patients: 12 patients meeting ICSD-criteria for narcolepsy. Interventions: Pharmacological treatment with reboxetine. Results: Following treatment for two-weeks, a significant improvement in daytime sleepiness could be observed, as reflected by a mean decrease of 48.6% on the Epworth Sleepiness Scale and a mean increase of 54.7% in sleep latency on the MSLT. Furthermore, a significant reduction in the cataplexy subscore of the Ullanlinna Narcolepsy Scale and in REM-sleep was found. Conclusions: Our results suggest that reboxetine exerts stimulant and anticataplectic effects in narcolepsy. Contrary to previous thinking, by which stimulant action would require dopaminergic facilitation, noradrenergic mechanisms might be relevant to the control of wakefulness.

69 citations

Journal ArticleDOI
TL;DR: This review summarizes the common methods used to measure sleep quality and compares the, specificity, and practicability of these methods and the status of sleep disturbance in patients with cancer is analyzed.
Abstract: Sleep disturbance is identified as a prominent concern in cancer patients with detrimental effect on health outcome, which accompanies a decline in functional status, reduces quality of life, and even accelerates deterioration of disease. Therefore, in order to design safe and effective therapy, and improve the quality of life in cancer patients, it is necessary to seek the optimal measures of sleep quality evaluation, which include the objective assessments (e.g., polysomnography [PSG], the bispectral index [BIS], actigraphy) and subjective assessments (e.g., Pittsburgh Sleep Quality Index [PSQI], Insomnia Severity Index [ISI], Epworth Sleepiness Scale [ESS], Consensus Sleep Diary [CSD]) and understand the status of sleep quality in cancer patients, especially patients with cancers in the breast, lung, head and neck, ovaries, and uterus. This review summarizes the common methods used to measure sleep quality and compares the sensitivity, specificity, and practicability of these methods. In addition, the status of sleep disturbance in patients with cancer is analyzed.

69 citations

Journal ArticleDOI
TL;DR: This study compared the predictive abilities of the STOP-Bang and Epworth Sleepiness Scale for screening sleep clinic patients for obstructive sleep apnea (OSA) and sleep-disordered breathing (SDB) and found the ESS had the highest specificity.
Abstract: This study compared the predictive abilities of the STOP-Bang and Epworth Sleepiness Scale (ESS) for screening sleep clinic patients for obstructive sleep apnea (OSA) and sleep-disordered breathing (SDB). Forty-seven new adult patients without previous diagnoses of OSA or SDB were administered the STOP-Bang and ESS and were assigned to OSA or SDB risk groups based on their scores. STOP-Bang responses were scored with two Body Mass Index cut points of 35 and 30 kg/m2 (SB35 and SB30). The tools� predictive abilities were determined by comparing patients� predicted OSA and SDB risks to their polysomnographic results. The SB30 correctly identi?ed more patients with OSA and SDB than the ESS alone. The ESS had the highest speci?city for OSA and SDB.

69 citations

Journal ArticleDOI
TL;DR: To evaluate the efficacy of base of tongue resection via transoral robotic surgery (TORS) in the treatment of obstructive sleep apnea/hypopnea syndrome (OSAHS).
Abstract: Objectives/Hypothesis To evaluate the efficacy of base of tongue (BOT) resection via transoral robotic surgery (TORS) in the treatment of obstructive sleep apnea/hypopnea syndrome (OSAHS). Study Design Case series Methods Between June 2010 and May 2012, BOT resection via TORS was performed on 27 patients with OSAHS. Patients were excluded from this analysis if other concomitant upper airway procedures such as uvulopalatopharyngoplasty were performed, or if postoperative polysomnograms were not available. Results Twelve patients who underwent BOT resection alone were included in this study. The median age for these 12 patients was 48.5 (range, 19–64) and included nine females and three males. The mean apnea-hypopnea index (AHI) was 43.9 ± 41.1 preoperatively and 17.6 ± 16.2 postoperatively. This difference in AHI was statistically significant (P = 0.007) and reflected an average AHI reduction of 56.2 ± 28.3%. Statistical significant reductions in daytime somnolence level, as measured by Epworth Sleepiness Scale (13.7 ± 5.2 preoperatively vs. 6.4 ± 4.5 postoperatively, P <0.001), and snoring intensity, as reported by a bed partner using a Visual Analogue Scale (8.6 ± 1.2 preoperatively vs. 4.2 ± 1.9 postoperatively, P <0.001), were achieved. There was no statistical significant difference between the preoperative and postoperative body mass index (34.5 ± 7.3 vs. 33.5 ± 6.7, P = 0.296) or minimum oxygen saturation (83.3 ± 5.5% vs. 84.0 ± 6.4%, P = 0.680). Conclusions This is the first study looking at the use of TORS to address obstruction at the level of BOT only, not confounded by surgical alterations at other levels of upper airway. This preliminary result on the use of BOT resection via TORS for the treatment of patients with OSAHS is encouraging and warrants further investigations. Level of Evidence 4. Laryngoscope, 2012

69 citations

Journal ArticleDOI
TL;DR: The results suggest an improvement in opioid-induced sedation in patients treated for nonmalignant pain, as measured using Epworth Sleepiness Scale.
Abstract: Study Objective. The purpose of this study was to assess the efficacy of modafinil in combating opioid-induced sedation. Design. A 1-year retrospective chart review of all patients receiving modafinil, a wake-promoting agent, to treat opioid-induced sedation. Opioid-induced sedation was measured using Epworth Sleepiness Scale (ESS). Setting. Outpatient, private practice. Patients. Eleven adult patients, six female and five male, being treated with opioids for chronic, nonmalignant pain. Results. A significant decrease was observed between pretreatment and posttreatment ESS measurements during modafinil treatment. Conclusion. The results suggest an improvement in opioid-induced sedation in patients treated for nonmalignant pain.

69 citations


Network Information
Related Topics (5)
Placebo
43K papers, 2.5M citations
76% related
Prospective cohort study
38.5K papers, 1.8M citations
75% related
Cohort
58.4K papers, 2M citations
74% related
Anxiety
141.1K papers, 4.7M citations
74% related
Odds ratio
68.7K papers, 3M citations
74% related
Performance
Metrics
No. of papers in the topic in previous years
YearPapers
2023348
2022689
2021370
2020367
2019356
2018319